+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Congenital Heart Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Congenital Heart Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Ethical Pharmaceuticals Market Report 2026 - Product Thumbnail Image

Ethical Pharmaceuticals Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Pharmaceutical Suppositories Market Report 2026 - Product Thumbnail Image

Pharmaceutical Suppositories Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Controlled Substance Market Report 2026 - Product Thumbnail Image

Controlled Substance Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Autoimmune Treatment Market Report 2026 - Product Thumbnail Image

Autoimmune Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Extended-Release Drugs Market Report 2026 - Product Thumbnail Image

Extended-Release Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Global CD19 Antibody Market & Clinical Pipeline Outlook 2028 - Product Thumbnail Image

Global CD19 Antibody Market & Clinical Pipeline Outlook 2028

  • Report
  • October 2023
  • 420 Pages
  • Global
From
Cell & Gene Therapy Market - Global Outlook & Forecast 2022-2027 - Product Thumbnail Image

Cell & Gene Therapy Market - Global Outlook & Forecast 2022-2027

  • Report
  • January 2022
  • 292 Pages
  • Global
From
From
Pulmonary Arterial Hypertension (PAH) Drugs Market 2024-2028 - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH) Drugs Market 2024-2028

  • Report
  • July 2024
  • 180 Pages
  • Global
From
a4ß7 Integrin Antagonists Market - Global Forecast 2026-2032 - Product Thumbnail Image

a4ß7 Integrin Antagonists Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 192 Pages
  • Global
From
Global Liposome Drug Delivery Market Analysis 2021-2031 - Product Thumbnail Image

Global Liposome Drug Delivery Market Analysis 2021-2031

  • Report
  • May 2022
  • 225 Pages
  • Global
From
PPARd Agonist Market - Global Forecast 2026-2032 - Product Thumbnail Image

PPARd Agonist Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 189 Pages
  • Global
From
Long-Acting Insulin Analogue Market - Global Forecast 2026-2032 - Product Thumbnail Image

Long-Acting Insulin Analogue Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 183 Pages
  • Global
From
Nanomedicine Market Report and Forecast 2023-2031 - Product Thumbnail Image

Nanomedicine Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 400 Pages
  • Global
From
JAK Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

JAK Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Exocrine Pancreatic Insufficiency Market Report 2026 - Product Thumbnail Image

Exocrine Pancreatic Insufficiency Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Alpha Mannosidosis Market Report 2026 - Product Thumbnail Image

Alpha Mannosidosis Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator